These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30566110)
1. The art of delivering evidence-based dual antiplatelet therapy. Curry WJ; Chambers CE; Curry GW; Curry EW J Fam Pract; 2018 Dec; 67(12):758-766. PubMed ID: 30566110 [TBL] [Abstract][Full Text] [Related]
2. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019 [TBL] [Abstract][Full Text] [Related]
3. Challenges of antiplatelet therapy in patients who require anticoagulation. Henkel DM; Holmes DR J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758 [No Abstract] [Full Text] [Related]
4. [Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation]. Gallet R; Teiger E Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):404-410. PubMed ID: 30342831 [TBL] [Abstract][Full Text] [Related]
5. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
6. Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention. Agarwal N; Mahtta D; Rambarat CA; Elgendy I; Mahmoud AN Biomed Res Int; 2018; 2018():5690640. PubMed ID: 29770334 [TBL] [Abstract][Full Text] [Related]
7. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine GN; Eur J Cardiothorac Surg; 2018 Jan; 53(1):34-78. PubMed ID: 29045581 [No Abstract] [Full Text] [Related]
19. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Bittl JA; Baber U; Bradley SM; Wijeysundera DN J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919 [TBL] [Abstract][Full Text] [Related]
20. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]